Myocardial Infarction Global Clinical Trials Review, H2, 2015 Now Available at iData Insights Myocardial Infarction Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, Myocardial Infarction Global Clinical Trials Review, H2, 2015" provides an overview of Myocardial Infarction clinical trials scenario. This report provides top line data relating to the clinical trials on Myocardial Infarction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Browse Complete Report with TOC http://www.idatainsights.com/reports-landingpage.php?id=173465/myocardial-infarction-global-clinical-trials-review-h2-2015 To Get Sample Copy of Report visit http://www.idatainsights.com/reports-landingpage.php?id=173465/myocardial-infarction-global-clinical-trials-review-h2-2015 Table of Contents Table of Contents 2 List of Tables 3 1
List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Myocardial Infarction to Cardiovascular Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Myocardial Infarction to Cardiovascular Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Myocardial Infarction Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Myocardial Infarction 31 Nov 10, 2015: New Haven Pharmaceuticals: Study Shows DURLAZA (aspirin) Extended-Release Capsules Delivers Sustained Antiplatelet Effects For Full 24 hours 31 Nov 10, 2015: PEGASUS-TIMI 54 Sub-Analysis Outlines Long-Term Tolerability Data for BRILINTA 31 Nov 10, 2015: PEGASUS-TIMI 54 Sub-Analysis Outlines Long-Term Tolerability Data for BRILINTA 32 Nov 02, 2015: New Haven Pharmaceuticals to Share DURLAZA Extended-Release Capsules Study Data At American Heart Association Scientific Sessions Fall Event. 33 Nov 02, 2015: Angion Biomedica to Present Clinical and Preclinical Data at the Upcoming American Society of Nephrology Conference in San Diego 34 Sep 23, 2015: TiGenix: AlloCSC-01 Phase I data Presented at the Congress of the European Society of Cardiology 34 Clinical Trial Profile Snapshots 36 Appendix 716 Abbreviations 716 Definitions 716 Research Methodology 717 Secondary Research 717 About GlobalData 718 Contact Us 718 Disclaimer 718 Source 719
2
Read More http://www.idatainsights.com/reports-landing-page.php?id=173465/myocardial-infarctionglobal-clinical-trials-review-h2-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future project.
3